What is a primary management recommendation for individuals at moderate risk of breast cancer?

Individuals identified as being at moderate risk for breast cancer should ideally be referred to a familial cancer clinic. This recommendation is rooted in the need for personalized risk assessment, genetic counseling, and tailored surveillance strategies. Moderately increased risk groups may include individuals with a family history of breast or ovarian cancer but who do not meet the criteria for high-risk management, such as those with BRCA1 or BRCA2 mutations.

Referral to a familial cancer clinic allows for a more comprehensive evaluation of family history and may lead to genetic testing if appropriate. This process can provide patients with crucial information regarding their risk levels, inform management strategies, and guide decisions about enhanced surveillance or preventive measures.

Other options, such as annual colonoscopy and screening for ovarian cancer, do not specifically address breast cancer risk management for individuals at moderate risk. Daily aspirin use is generally not recommended as a primary preventive strategy for breast cancer in this demographic, as it does not contribute significantly to breast cancer-specific risk reduction. Instead, the focus for those at moderate risk should be on proper assessment and potential management options available through specialized clinics.